Outset Medical (OM) Revenue Growth (1y) (2020 - 2026)
Outset Medical (OM) Revenue Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.51 Bn | 174.21 Bn | 6.27 Bn | 7.78% |
| 2 | Stryker | 128.52 Bn | 125.64 Bn | 3.81 Bn | 2.63% |
| 3 | Medtronic | 108.06 Bn | 98.84 Bn | 6.41 Bn | 9.86% |
| 4 | Boston Scientific | 68.04 Bn | 66.59 Bn | 3.61 Bn | 11.58% |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn | 16.70% |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.17 Bn | 1.98 Bn | 7.41% |
| 7 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | 15.05% |
| 8 | Smith & Nephew | 26.88 Bn | 26.30 Bn | - | - |
| 9 | Koninklijke Philips | 25.42 Bn | 22.29 Bn | 2.07 Bn | 6.08% |
| 10 | Outset Medical | 75,880.49 | -286.57 Mn | 12.10 Mn | -6.35% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.35% |
| Dec 31, 2025 | -2.01% |
| Sep 30, 2025 | 2.67% |
| Jun 30, 2025 | 14.72% |
| Mar 31, 2025 | 5.62% |
| Dec 31, 2024 | -3.41% |
| Sep 30, 2024 | -5.59% |
| Jun 30, 2024 | -24.01% |
| Mar 31, 2024 | -15.83% |
| Dec 31, 2023 | -4.69% |
| Sep 30, 2023 | 9.37% |
| Jun 30, 2023 | 43.83% |
| Mar 31, 2023 | 9.55% |
| Dec 31, 2022 | 13.69% |
| Sep 30, 2022 | 5.48% |
| Jun 30, 2022 | -0.63% |
| Mar 31, 2022 | 33.31% |
| Dec 31, 2021 | 63.23% |
| Sep 30, 2021 | 91.32% |
| Jun 30, 2021 | 114.75% |